693 Advances in Metabolic Engineering II: Value-Added Products from Renewable Feedstocks


Description:
Metabolic engineering is the targeted improvement of the cellular metabolic phenotype using recombinant DNA technology. This session emphasizes pathway-level engineering. Approaches are typically mostly experimental and are focused on a specific pathway and metabolites rather than metabolism as a whole. Example areas include: strategies to enhance the production of natural products, pathway engineering for the production of novel products, and the application of evolutionary techniques for improving production of a metabolite. Abstracts describing new developments in these topics are sought, and the session is open to papers focused on any type of organism, microbial consortium, or cell-free system.

Sponsor:
Bioengineering


Chair:
Jose L. Avalos
Assistant Professor
Princeton University
Department of Chemical and Biological Engineering
9 Cambridge Center
Princeton, NJ
02142
Phone Number: 6092589881
Fax Number: 6092581247
Email: javalos@princeton.edu

Co-Chair:
Nathan Crook
The University of Texas at Austin
Department of Chemical Engineering
1 University Station C0400
Austin, TX
78712-0231
Email: ncrook@wustl.edu


Papers:
693a
Solvent Production Using a CO2 - Fixing, Synthetic, and Syntrophic Clostridium Co-Culture
Kamil Charubin, University of Delaware; Eleftherios Terry Papoutsakis, University of Delaware
693b
Engineering E. coli to Consume Methanol
Benjamin Woolston, MIT; Jason King, Massachusetts Institute of Technology; Michael Reiter, MIT; Gregory Stephanopoulos, MIT
693c
Removal of Ribosome Stalling Motifs to Improve Oxygenation of Key Intermediate in the Taxol Pathway
John Lazar, Northwestern University; Bradley W. Biggs, Northwestern University; Keith E.J. Tyo, Northwestern University
693d
Engineering Yarrowia Lipolytica for the Production of Triacetic Acid Lactone
Kelly Markham, The University of Texas at Austin; Claire Palmer, University of Texas at Austin; Clare Murray, University of Texas at Austin; Hal Alper, The University of Texas at Austin
693e
Engineering a Novel Omega-3 Fatty Acid Biosynthesis Pathway in Yarrowia Lipolytica
Difeng Gao, Clemson University; Mark Blenner, Clemson University
693f
Establishing a Novel and Efficient Biosynthetic Pathway for Anticoagulant Precursor 4-Hydroxycoumarin in Engineered Escherichia coli
Xiaolin Shen, University of Georgia; Yuheng Lin, BiotecEra Inc.; Monika Mahajani, BiotecEra Inc.; Jia Wang, University of Georgia; Qipeng Yuan, Beijing University of Chemical Technology; Yajun Yan, University of Georgia
693g
Metabolic Engineering and/or Synthetic Biology for Improved Biotechnological Production: Promises and Realities
Eleftherios Terry Papoutsakis, University of Delaware
Abstract Submissions Closed
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
<< Previous Session | Next Session >>